M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_00524

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_00524 6 0.12 Mlig455_035116

Neo: -

Age: -

 Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF}

Cumulative graph for MligTC455_00524

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 - - - -
RegionR2 - - - -
RegionR3 - - - -
RegionR4 - - - -
RegionR5 - - - -
RegionR6 - - - -
RegionR7 - - - -
RegionR8 - - - -

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 - - - -
RegenerationR2 - - - -
RegenerationR3 - - - -
RegenerationR4 - - - -
RegenerationR5 - - - -
RegenerationR6 - - - -
RegenerationBL - - - -
RegenerationTP - - - -


Genes with expression patterns similar to MligTC455_00524

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_00524 6 0.12 Mlig455_035116

Neo: -

Age: -

 1 - - 1.000 - - - Mlig455_035116 {REF} {Length: 886} {NoTransDecoderORF}
2. MligTC455_10386 40 0.84 Mlig455_016460, Mlig455_016526, Mlig455_049813

Neo: -

Age: Up-Down-Down

 CHRNA2, CHRNA6 1 - - 1.000 - - -

Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177}

Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177}

Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177}
3. MligTC455_11476 26 0.54 Mlig455_035212

Neo: -

Age: -

 1 - - 1.000 - - - Mlig455_035212 {REF} {Length: 1374} {RNA1310_88897} {RNA815_51066}
4. MligTC455_39681 136 2.83 Mlig455_045908, Mlig455_045958, Mlig455_063327

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-0.624

Region-enriched R2: 4.082/0.00717
Region-enriched R8: 3.863/0.01304

 CASP1, CASP7 1 - - 1.000 - - -

Mlig455_045908 {REF} {Length: 1556} {NoTransDecoderORF} {RNA1310_115705} {RNA815_46116}

Mlig455_045958 {REF} {Length: 1362} {Pfam: Caspase domain [PF00656.24, score=68.0]} {Human: ENSG00000165806, CASP7, caspase 7, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=58.9, Expect=1e-09]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=53.1, Expect=6e-08]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=49.7, Expect=4e-07]} {RNA1310_50397} {RNA815_46116}

Mlig455_063327 {REF} {Length: 3941} {Pfam: Caspase domain [PF00656.24, score=81.3]} {Human: ENSG00000137752, CASP1, caspase 1, [Score=79.7, Expect=1e-15]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=82.8, Expect=1e-16]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=63.2, Expect=2e-10]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=75.9, Expect=6e-15]} {Smed: dd_Smed_v6_1167_0_1, dd_Smed_v6_1167_0_1, [Score=73.9, Expect=1e-14]} {RNA1509_50041} {RNA1310_2539.1} {RNA815_252.1}
5. MligTC455_05874 5 0.11 Mlig455_049976

Neo: -

Age: -

 0.996 - - 0.996 - - - Mlig455_049976 {REF} {Length: 389} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_109621}
6. MligTC455_12355 27 0.56 Mlig455_024618

Neo: -

Age: -

 CHRNA3 0.988 - - 0.988 - - - Mlig455_024618 {REF} {Length: 2865} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=270.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=246.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [RH, Score=432, Expect=7e-146]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [RH, Score=432, Expect=5e-146]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [RH, Score=419, Expect=1e-140]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [RH, Score=427, Expect=6e-144]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [RH, Score=426, Expect=2e-143]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [RH, Score=418, Expect=1e-140]; ENSMUSG00000035200, Chrnb4, cholinergic receptor, nicotinic, beta polypeptide 4, [RH, Score=406, Expect=4e-136]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [RH, Score=524, Expect=0.0]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=459, Expect=4e-157]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [RH, Score=521, Expect=6e-180]} {RNA1509_36802} {RNA1310_50512} {RNA815_3014.1}
7. MligTC455_12438 17 0.35 Mlig455_009594

Neo: -

Age: -

 0.988 - - 0.988 - - - Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274}
8. MligTC455_13493 28 0.58 Mlig455_020299

Neo: -

Age: -

 0.988 - - 0.988 - - - Mlig455_020299 {REF} {Length: 568} {RNA1310_11315} {RNA815_53929}
9. MligTC455_15134 15 0.31 Mlig455_000804

Neo: -

Age: -

 CNGA3 0.988 - - 0.988 - - - Mlig455_000804 {REF} {Length: 2294} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=62.8]; Ion transport protein [PF00520.33, score=39.4]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=351, Expect=2e-113]; ENSG00000198515, CNGA1, cyclic nucleotide gated channel alpha 1, [Score=344, Expect=2e-110]; ENSG00000183862, CNGA2, cyclic nucleotide gated channel alpha 2, [Score=340, Expect=2e-109]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=352, Expect=9e-115]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=342, Expect=7e-110]; ENSMUSG00000005864, Cnga2, cyclic nucleotide gated channel alpha 2, [Score=338, Expect=9e-109]} {Dmel: FBgn0259145, CG42260, [Score=463, Expect=1e-153]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=281, Expect=1e-86]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=343, Expect=2e-111]} {RNA1310_120793} {RNA815_25814}
10. MligTC455_15160 11 0.23 Mlig455_024917

Neo: -

Age: -

 0.988 - - 0.988 - - - Mlig455_024917 {REF} {Length: 773} {TRANSSPLICED} {RNA1310_98042}
11. MligTC455_18788 27 0.57 Mlig455_040989, Mlig455_040991

Neo: -

Age: -

 0.988 - - 0.988 - - -

Mlig455_040989 {REF} {Length: 1277} {RNA1509_56938} {RNA1310_39299} {RNA815_53904}

Mlig455_040991 {REF} {Length: 1852} {RNA1509_56938} {RNA1310_34736} {RNA815_16785.1}
12. MligTC455_36252 20 0.42 Mlig455_050668

Neo: -

Age: -

 PRKAR2B 0.988 - - 0.988 - - - Mlig455_050668 {REF} {Length: 1234} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=45.2]} {Human: ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=93.2, Expect=9e-21]} {Mouse: ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=93.2, Expect=7e-21]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=96.3, Expect=3e-22]} {Smed: dd_Smed_v6_1362_0_1, dd_Smed_v6_1362_0_1, [Score=87.8, Expect=2e-19]}
13. MligTC455_54226 52 1.09 Mlig455_037435, Mlig455_037458

Neo: -

Age: -

 NETO2 0.988 - - 0.988 - - -

Mlig455_037435 {REF} {Length: 2663} {Pfam: CUB domain [PF00431.22, score=52.2]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [Score=96.3, Expect=3e-20]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [Score=97.8, Expect=6e-21]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=87.8, Expect=1e-17]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=77.4, Expect=4e-15]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=87.0, Expect=1e-17]} {RNA1310_38111}

Mlig455_037458 {REF} {Length: 2349} {Pfam: CUB domain [PF00431.22, score=52.1]; Low-density lipoprotein receptor domain class A [PF00057.20, score=31.7]} {Human: ENSG00000171208, NETO2, neuropilin and tolloid like 2, [RH, Score=144, Expect=9e-37]} {Mouse: ENSMUSG00000036902, Neto2, neuropilin (NRP) and tolloid (TLL)-like 2, [RH, Score=146, Expect=1e-37]} {Dmel: FBgn0265416, Neto, Neuropilin and tolloid-like, [Score=117, Expect=2e-27]} {Celegans: WBGene00019360, neto-1, NETO (NEuropilin and TOlloid-like) homolog, [Score=105, Expect=1e-24]} {Smed: dd_Smed_v6_8579_0_1, dd_Smed_v6_8579_0_1, [Score=115, Expect=6e-27]} {RNA1310_38111}
14. MligTC455_23809 119 2.47 Mlig455_065200

Neo: -

Age: -

 0.979 - - 0.979 - - - Mlig455_065200 {REF} {Length: 2060} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=33.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042}
15. MligTC455_43783 8 0.17 Mlig455_018589

Neo: -

Age: -

 0.979 - - 0.979 - - - Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]}
16. MligTC455_41475 43 0.89 Mlig455_021663, Mlig455_021712

Neo: -

Age: -

 0.977 - - 0.977 - - -

Mlig455_021663 {REF} {Length: 486} {NoTransDecoderORF} {RNA1310_96898}

Mlig455_021712 {REF} {Length: 812} {NoTransDecoderORF} {RNA1310_96898}
17. MligTC455_49949 46 0.95 Mlig455_069056

Neo: -

Age: -

 ASIC1 0.976 - - 0.976 - - - Mlig455_069056 {REF} {Length: 2381} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=204.6]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.2, Expect=2e-08]; ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=76.6, Expect=2e-14]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [Score=94.4, Expect=4e-20]} {RNA1509_44792} {RNA1310_8631} {RNA815_5782}
18. MligTC455_32832 57 1.19 Mlig455_011184, Mlig455_011216, Mlig455_024755

Neo: -

Age: -

 0.961 - - 0.961 - - -

Mlig455_011184 {REF} {Length: 466} {NoTransDecoderORF}

Mlig455_011216 {REF} {Length: 466} {NoTransDecoderORF}

Mlig455_024755 {REF} {Length: 451} {NoTransDecoderORF}
19. MligTC455_08407 22 0.46 Mlig455_043162

Neo: -

Age: -

 0.958 - - 0.958 - - - Mlig455_043162 {REF} {Length: 1257} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.7]} {RNA1310_58288} {RNA815_55196}
20. MligTC455_14860 14 0.3 Mlig455_033599

Neo: -

Age: -

 0.958 - - 0.958 - - - Mlig455_033599 {REF} {Length: 1075} {NoTransDecoderORF} {RNA1509_32111} {RNA1310_130308} {RNA815_53107.2}
21. MligTC455_24197 48 1 Mlig455_062645

Neo: -

Age: -

 KCNH7 0.95 - - 0.950 - - - Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448}
22. MligTC455_27078 22 0.46 Mlig455_028337, Mlig455_066176

Neo: -

Age: -

 0.95 - - 0.950 - - -

Mlig455_028337 {REF} {Length: 887} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083}

Mlig455_066176 {REF} {Length: 883} {NoTransDecoderORF} {RNA1509_59553} {RNA1310_69307} {RNA815_55083}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA